» Articles » PMID: 10411940

Cancer Dormancy and Cell Signaling: Induction of P21(waf1) Initiated by Membrane IgM Engagement Increases Survival of B Lymphoma Cells

Overview
Specialty Science
Date 1999 Jul 21
PMID 10411940
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The p21(WAF1) (p21) cyclin-dependent kinase inhibitor plays a major role in regulating cell cycle arrest. It was recently reported that the p53-independent elevation of p21 protein levels is essential in mediating the G(1) arrest resulting from signal transduction events initiated by the crosslinking of membrane IgM on Daudi Burkitt lymphoma cells. Although the role of p21 in cell cycle regulation is well documented, there is little information concerning its role in antibody-mediated apoptosis. In the present study, we examined the involvement of p21 in the regulation of apoptosis by suppressing its induction in anti-IgM-treated Daudi cells through a p21 antisense expression construct approach. Reduction in induced p21 protein levels resulted in diminished G(1) arrest and increased apoptosis. The increased susceptibility to anti-IgM-mediated apoptosis was associated with increased caspase-3-like activity and poly-(ADP)ribose polymerase cleavage. These data suggest that p21 may directly interfere with the caspase cascade, thus playing a dual role in regulating both cell cycle progression and apoptosis.

Citing Articles

HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer.

Edwards C, Clements M, Vecchi 3rd L, Johnson J, Johnson R J Bone Oncol. 2021; 31:100407.

PMID: 34934614 PMC: 8661052. DOI: 10.1016/j.jbo.2021.100407.


Epigenetic Silencing of BMP6 by the SIN3A-HDAC1/2 Repressor Complex Drives Melanoma Metastasis via FAM83G/PAWS1.

Min D, Byun J, Lee E, Khan A, Liu C, Loudig O Mol Cancer Res. 2021; 20(2):217-230.

PMID: 34610961 PMC: 9744461. DOI: 10.1158/1541-7786.MCR-21-0289.


The current paradigm and challenges ahead for the dormancy of disseminated tumor cells.

Risson E, Nobre A, Maguer-Satta V, Aguirre-Ghiso J Nat Cancer. 2021; 1(7):672-680.

PMID: 33681821 PMC: 7929485. DOI: 10.1038/s43018-020-0088-5.


Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy.

Triana-Martinez F, Loza M, Dominguez E Cells. 2020; 9(2).

PMID: 32028565 PMC: 7072600. DOI: 10.3390/cells9020346.


Controversies in clinical cancer dormancy.

Uhr J, Pantel K Proc Natl Acad Sci U S A. 2011; 108(30):12396-400.

PMID: 21746894 PMC: 3145712. DOI: 10.1073/pnas.1106613108.


References
1.
Demidem A, Lam T, Alas S, Hariharan K, Hanna N, Bonavida B . Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm. 1997; 12(3):177-86. DOI: 10.1089/cbr.1997.12.177. View

2.
Taji H, Kagami Y, Okada Y, Andou M, Nishi Y, Saito H . Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody. Jpn J Cancer Res. 1998; 89(7):748-56. PMC: 5921892. DOI: 10.1111/j.1349-7006.1998.tb03280.x. View

3.
Hudziak R, Lewis G, Winget M, Fendly B, Shepard H, Ullrich A . p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol. 1989; 9(3):1165-72. PMC: 362707. DOI: 10.1128/mcb.9.3.1165-1172.1989. View

4.
Page D, DeFranco A . Antigen receptor-induced cell cycle arrest in WEHI-231 B lymphoma cells depends on the duration of signaling before the G1 phase restriction point. Mol Cell Biol. 1990; 10(6):3003-12. PMC: 360664. DOI: 10.1128/mcb.10.6.3003-3012.1990. View

5.
Levy R, Miller R . Therapy of lymphoma directed at idiotypes. J Natl Cancer Inst Monogr. 1990; (10):61-8. View